Alerus (ALRS) Q1 2026 Earnings Transcript

Alerus Financial reported Q1 net income of $23 million, or $0.89 per diluted share, with ROA of 1.79% and ROTCE of 21.96%, helped by an 8 bps NIM expansion to 3.77% and a 139 bps increase in investment portfolio yield to 3.84%. Deposits rose 3.7% sequentially, the loan-to-deposit ratio improved to 92.8%, and credit quality strengthened as nonperforming assets fell $15.4 million and criticized loans declined 43% year over year. Management guided to 2026 NIM of 3.55%-3.65%, mid-single-digit loan growth, and ROA above 1.25%, while continuing buybacks with $6 million repurchased in the quarter.

Analysis

The key incremental takeaway is that ALRS is shifting from a “rate-beta” story to a more self-help compounder: the core margin step-up came from funding mix, portfolio reset, and deposit franchise quality, not from one-off accounting noise. That matters because the implied earnings durability is now more tied to controllable levers—mix, pricing, and fee integration—than to the next Fed move. The market may still be underestimating how much the business can re-rate if deposit stability holds through the typical public-fund runoff window in Q2/Q3.

The credit story is better than the headline reserve release suggests. Management is actively shrinking the tail of criticized and nonaccrual assets while exiting lower-return CRE, which should reduce volatility in future provision even if reported growth looks mediocre for a couple quarters. The second-order effect is that less balance-sheet drag and lower complexity should improve operating leverage in 2H26, especially if C&I pipelines convert as expected and wealth hires begin to contribute.

The main risk is that the “best quarter” setup is partially forward-loaded: accretion rolls off, deposit costs re-price higher, and seasonal public-fund outflows can compress the margin from the March exit rate. In other words, the stock can still work on a 6–12 month view, but near-term beats may fade and the multiple could stall if loan growth in Q2 remains muted. The contrarian angle is that the market may focus too much on the deposit cost pressure and miss that management is deliberately trading low-yield/low-quality assets for a cleaner, higher-ROA franchise; that usually looks expensive right before it looks obvious.

If the company executes, ALRS should screen more like a capital-returning niche bank with fee income support than a cyclical lender, which supports a higher P/TBV than the current setup implies. The asymmetry is favorable, but only if credit normalization continues and the deposit base doesn’t prove more rate-sensitive than management expects.

Key Decisions for Investors

• Long ALRS on a 3–6 month horizon; use pullbacks tied to Q2 margin fears as entry points. Risk/reward is attractive if the market is over-discounting accretion roll-off versus cleaner core margin and buyback support.
• Pair trade: long ALRS / short a higher-beta regional bank with weaker fee mix and higher CRE exposure. The thesis is that ALRS deserves a relative premium as it de-risks assets and sustains >40% fee revenue.
• Buy ALRS common with a 12-month target tied to TBV compounding plus buybacks; downside is limited by capital strength and reserve coverage, while upside comes from multiple expansion if ROA stays above 1.25%.
• For event-driven traders, consider selling puts or using call spreads into expected Q2 weakness if deposit seasonality pressures the stock. The trade benefits from volatility around guidance resets while capping premium outlay.
• Watch for confirmation in 2H26 C&I growth and deposit mix; if those inflect, add to longs. If core margin slips below the low end of guidance without offsetting loan growth, reduce exposure.